scholarly journals Effects of Diaphragmatic Breathing on Health: A Narrative Review

Medicines ◽  
2020 ◽  
Vol 7 (10) ◽  
pp. 65
Author(s):  
Hidetaka Hamasaki
Keyword(s):  
Functional Constipation ◽  
Treatment Method ◽  
Poor Quality ◽  
Narrative Review ◽  
Current Evidence ◽  
Chronic Obstructive ◽  
Diaphragmatic Breathing ◽  
Obstructive Pulmonary Disease ◽  
Pubmed Search

Background: Breathing is an essential part of life. Diaphragmatic breathing (DB) is slow and deep breathing that affects the brain and the cardiovascular, respiratory, and gastrointestinal systems through the modulation of autonomic nervous functions. However, the effects of DB on human health need to be further investigated. Methods: The author conducted a PubMed search regarding the current evidence of the effect of DB on health. Results: This review consists of a total of 10 systematic reviews and 15 randomized controlled trials (RCTs). DB appears to be effective for improving the exercise capacity and respiratory function in patients with chronic obstructive pulmonary disease (COPD). Although the effect of DB on the quality of life (QoL) of patients with asthma needs to be investigated, it may also help in reducing stress; treating eating disorders, chronic functional constipation, hypertension, migraine, and anxiety; and improving the QoL of patients with cancer and gastroesophageal reflux disease (GERD) and the cardiorespiratory fitness of patients with heart failure. Conclusions: Based on this narrative review, the exact usefulness of DB in clinical practice is unclear due to the poor quality of studies. However, it may be a feasible and practical treatment method for various disorders.

Palliative Care in End-Stage Chronic Obstructive Pulmonary Disease

2018 ◽  
Author(s):  
Linh My Thi Nguyen
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Palliative Care ◽  
Pulmonary Disease ◽  
Symptom Burden ◽  
Symptom Assessment ◽  
Poor Quality ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
End Stage

Patients with end-stage chronic obstructive pulmonary disease (COPD) experience high symptom burden due to severe dyspnea, fatigue, anxiety, depression, disability, and social isolation, resulting in poor quality of life. The caregiving burden for the family is also severe. Despite high symptom burden, because of limited access and difficulty with prognostication, the quality of care for patients with end-stage COPD who receive palliative care compares poorly to the care received by patients with cancer, and the proportion of COPD patients who receive palliative care is much lower than that of cancer patients. Therefore, patients with COPD receive less palliative care and die following more aggressive treatments at the end of life compared to patients with lung cancer, despite having the same preferences for palliative care. This chapter discusses the key issues related to end-stage COPD, including symptom assessment, management, and hospice eligibility.

Tracheobronchomalacia and Excessive Dynamic Airway Collapse: Medical and Surgical Treatment

2018 ◽  
Vol 39 (06) ◽  
pp. 667-673 ◽  
Author(s):  
Fayez Kheir ◽  
Adnan Majid
Keyword(s):  
Clinical Symptoms ◽  
Respiratory Infections ◽  
Poor Quality ◽  
Current Evidence ◽  
Vocal Cord Dysfunction ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Symptom Profile ◽  
Airway Collapse ◽  
Central Airway

AbstractExcessive central airway collapse (ECAC) is characterized by excessive narrowing of the airway lumen during exhalation leading to dyspnea, cough, mucostasis, recurrent respiratory infections, and poor quality of life. Tracheobronchomalacia and excessive dynamic airway collapse are heterogeneous entities of ECAC and are characterized by a diverse nonspecific symptom profile. Although the pathophysiology of airway mechanics as well as morphology in both entities is different, current evidence so far shows no practical benefit in making such distinction since both have similar symptoms and the diagnostic and therapeutic work-ups are the same. The diagnosis of ECAC should be based on dynamic flexible bronchoscopy and/or dynamic computed tomography scan as well as clinical symptoms that are not fully explained by other lung diseases. Initial treatment of symptomatic ECAC includes treatment of coexisting conditions (such as chronic obstructive pulmonary disease, asthma, gastroesophageal reflux disease, and vocal cord dysfunction) and supportive treatment of dynamic central airway collapse (antibiotics for respiratory infections, aggressive therapy, pulmonary physiotherapy, pulmonary rehabilitation, and continuous positive airway pressure). A short-term stent trial in selected patients with severe symptomatic ECAC is needed to assess whether patients will have improvement in symptoms and thus identify patients who will benefit from surgical central airway stabilization. A multidisciplinary airway team in highly specialized centers with experience in the evaluation and treatment of this patient population is essential for optimal outcomes.

scholarly journals Quality of life in patients with chronic obstructive pulmonary disease at Pulmonary Community Health Centre Makassar

2018 ◽  
Vol 5 (9) ◽  
pp. 3753
Author(s):  
Elva Cristy Irianti ◽  
Arsunan A. A. ◽  
M. Tahir Abdullah
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Multivariate Analysis ◽  
Community Health ◽  
Pulmonary Disease ◽  
Poor Quality ◽  
Chronic Obstructive ◽  
Quality Of Sleep ◽  
Obstructive Pulmonary Disease

Background: Chronic obstructive pulmonary disease (COPD) that causes damage to lung conditions such as dyspnea that affects to social and psychological life of the sufferer which overall affects the quality of life. This reaserch aims to focuses on factors related to the quality of life patients with COPD at the Pulmonary Community Health Center, Makassar.Methods: This study used cross sectional study design. Population in this research were patients with COPD who undergo treatment period of October-December 2017 that was as much as 381. Sampling was done by consecutive sampling with total sampel 160 responden. Data analysis consisted of univariate, bivariate with chi square test and multivariate analysis with logistic regression.Results: The results showed that some respondents had poor quality of life (63.8%) and other respondents had a good quality of life (36.3%). Factors related to quality of life were the severity of COPD (p=0.028), comorbidity (p=0.001) and quality of sleep (p=0.005). A multivariate analysis showed that patients with comorbidity were at risk 2,716 times to have poor quality of life.Conclusions: The severity of COPD, comorbidity and quality of sleep were related to have poor quality of life. Patients with COPD should early diagnosis of severity and should change their lifestyle better so as not to aggravate the quality of life.

scholarly journals Prevalencia de comorbilidad en pacientes con enfermedad pulmonar obstructiva crónica

Duazary ◽  
2018 ◽  
Vol 15 (3) ◽  
pp. 273
Author(s):  
John Carlos Pedrozo-Pupo ◽  
Adalberto Campo-Arias ◽  
Héctor De La Torre
Keyword(s):  
Quality Of Life ◽  
Cross Sectional Study ◽  
Poor Quality ◽  
Chronic Obstructive ◽  
Cross Sectional ◽  
Obstructive Pulmonary Disease ◽  
Copd Assessment Test ◽  
Enfermedad Pulmonar Obstructiva Crónica ◽  
The Relationship

Comorbidity is common in patients with chronic obstructive pulmonary disease (COPD); however, the relationship between comorbidity and quality of life is inconsistent. The objective was to establish the prevalence of comorbidity and the relationship with the quality of life of patients with COPD in Santa Marta, Colombia. A cross-sectional study was designed in which in which participated outpatients diagnosed with COPD. Quality of life was evaluated with the CAT (COPD Assessment Test) instrument; scores higher than ten were considered poor quality of life. The sample was of 292 patients, in ages between 49 and 95 years; 61.6% male. A group of 232 participants (79.5%) presented some comorbidity associated with COPD. Quality of life was reduced in 192 patients (65.8%). Comorbidity did not significantly add to the quality of life (OR = 1.33, 95% CI 0.72-2.45), adjusted for age and sex. It is concluded that comorbidity is very frequent; however, it does not affect the quality of life in patients with COPD in Santa Marta. More research is needed with more participants.

Sign in / Sign up

Export Citation Format

Share Document